Benzyl isothiocyanate exhibits antibacterial and antibiofilm activity against Fusobacterium nucleatum while preserving viability of human bone marrow mesenchymal stem cells: an in vitro study
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1683203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Abdulaziz A Almobarak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Restorative Dental Sciences, Endodontic Division, College of Dentistry, King Saud University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Fusobacterium nucleatum, Mesenchymal Stem Cells, Biofilms, Anti-Bacterial Agents. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Regenerative endodontic procedures require effective disinfection and preservation of stem cell viability, which are essential for successful tissue regeneration. Conventional intracanal medicaments possess antibacterial properties but may negatively impact stem cell survival. Benzyl isothiocyanate (BITC) is a bioactive compound with known antibacterial properties and favorable biocompatibility.
Methods
This study evaluated the antibacterial efficacy of BITC against Fusobacterium nucleatum in both planktonic and biofilm forms and assessed its biocompatibility on human bone marrow mesenchymal stem cells (hBMMSCs) in comparison to calcium hydroxide (Ca(OH) 2 ). Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined using microdilution and agar culture methods. Biofilm biomass was quantified using the crystal violet assay, viability was visualized through live/dead imaging, and microstructure was examined using scanning electron microscopy. Stem cell viability was evaluated using the Alamar Blue™ assay, and cell morphology was examined using inverted microscopy.
Results
BITC exhibited MIC and MBC values of 0.2% and 0.4%, respectively. At 0.2%, BITC demonstrated comparable antibacterial activity to Ca(OH) 2 , whereas 0.4% and 0.8% showed enhanced bactericidal effects. Notably, 0.2% and 0.4% BITC maintained hBMMSCs viability and morphology, while 0.8% BITC and Ca(OH) 2 significantly reduced cell survival.
Conclusion
These findings suggest that BITC could serve as a potential antimicrobial agent in regenerative endodontic treatment and future therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Restorative Dental Sciences, Endodontic Division, College of Dentistry, King Saud University, Riyadh, Saudi Arabia.
- Department of Prosthetic Dental Sciences, College of Dentistry, King Saud University, Riyadh, Saudi Arabia.
- Molecular and Cell Biology Laboratory, Prince Naif bin Abdulaziz Health Research Center, King Saud University Medical City, Riyadh, Saudi Arabia.
- Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, King Saud University, Riyadh, Saudi Arabia.
Zitieren
APA
Almobarak, A. A., Alqedairi, A., Binrayes, A., Lambarte, R. A., Niazy, A. A., & Aljarbou, F. (2025). Benzyl isothiocyanate exhibits antibacterial and antibiofilm activity against Fusobacterium nucleatum while preserving viability of human bone marrow mesenchymal stem cells: an in vitro study. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1683203
Vancouver
Almobarak AA, Alqedairi A, Binrayes A, Lambarte RA, Niazy AA, Aljarbou F. Benzyl isothiocyanate exhibits antibacterial and antibiofilm activity against Fusobacterium nucleatum while preserving viability of human bone marrow mesenchymal stem cells: an in vitro study. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1683203
BibTeX
@article{Almobarak2025,
author = {Almobarak, Abdulaziz A and Alqedairi, Abdullah and Binrayes, Abdulaziz and Lambarte, Rhodanne A and Niazy, Abdurahman A and Aljarbou, Fahd},
title = {Benzyl isothiocyanate exhibits antibacterial and antibiofilm activity against Fusobacterium nucleatum while preserving viability of human bone marrow mesenchymal stem cells: an in vitro study},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1683203}
}
EUVIMED